Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Return on Assets (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Return on Assets for 4 consecutive years, with 0.31% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 19.0% to 0.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.31% through Dec 2025, up 19.0% year-over-year, with the annual reading at 0.4% for FY2025, 11.0% up from the prior year.
  • Return on Assets hit 0.31% in Q4 2025 for Taysha Gene Therapies, down from 0.29% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.29% in Q3 2025 to a low of 1.39% in Q4 2022.
  • Historically, Return on Assets has averaged 0.65% across 4 years, with a median of 0.48% in 2024.
  • Biggest five-year swings in Return on Assets: surged 99bps in 2023 and later dropped -10bps in 2024.
  • Year by year, Return on Assets stood at 1.39% in 2022, then soared by 71bps to 0.4% in 2023, then decreased by -24bps to 0.5% in 2024, then soared by 38bps to 0.31% in 2025.
  • Business Quant data shows Return on Assets for TSHA at 0.31% in Q4 2025, 0.29% in Q3 2025, and 0.37% in Q2 2025.